BONK, INC. current report, 03 November 2020

Full document

Filing Summary

Reporting period and filing context: This Form 8-K was filed by Jupiter Wellness, Inc. on November 4, 2020, reporting events occurring November 3, 2020. The provided request metadata identifies the company as BONK, INC.; however, the filing itself identifies the registrant as Jupiter Wellness, Inc., with common stock trading under JUPW and warrants under JUPWW.

Business and Transaction Context

The filing reports the completion of Jupiter Wellness’s initial public offering on November 3, 2020. The IPO consisted of 933,333 units, with each unit comprising one share of common stock and one warrant exercisable for one share of common stock at $8.50 per share.

Financial Metrics and Capitalization

  • IPO offering price: $7.50 per unit.
  • Gross IPO proceeds: approximately $7.0 million.
  • Additional warrants sold in connection with the underwriters’ over-allotment option: 140,000 warrants at $0.01 per warrant.
  • Gross proceeds from additional warrants: $1,400.
  • The filing does not provide revenue, profit, cash flow, operating margin, debt, cash balance, net proceeds, or liquidity figures.

Material Changes and Unusual Items

  • The company completed its IPO and issued 933,333 shares and 933,333 warrants through the units.
  • The company simultaneously sold 140,000 additional warrants that were subject to the underwriters’ 45-day over-allotment option.
  • The filing does not provide a prior comparable period or operating-period financial results for comparison.

Guidance, Outlook, and Risks

The filing does not provide financial guidance, management outlook, risk-factor updates, contingencies, or detailed use-of-proceeds information. The registration statement for the IPO was declared effective by the SEC on October 30, 2020.

Investor Verification Items

  • Verify the registrant identity because the filing names Jupiter Wellness, Inc., while the request metadata names BONK, INC.
  • Confirm the final IPO share and warrant counts, including any subsequent exercise of the over-allotment option.
  • Review the registration statement and subsequent filings for underwriting discounts, offering expenses, net proceeds, and intended use of funds.
  • Check subsequent periodic filings for the company’s post-IPO cash position, operating performance, debt, dilution, and warrant obligations.